Human Genome Sciences
Article Abstract:
A comparative analysis of the company sales and financial details of Human Genome Sciences, Inc. from 1994 to 2003 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Genzyme General
Article Abstract:
Revenues of Genzyme General, a division of Genzyme Corp., from sales of Cerezyme and Renagel will heavily influence shareprice in the the near term. Timely stock long-term capital gains potential out to 2006 and 2008. is affected competitive generic by Oxford GlycoScience .
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic: